SPDR S&P U.S. Health Care Select Sector UCITS ETF USD

Reference Data

ISIN IE00BWBXM617
Valor Number 28805622
Bloomberg Global ID
Fund Name SPDR S&P U.S. Health Care Select Sector UCITS ETF USD
Fund Provider State Street Global Advisors Beethovenstrasse 19, 8002 Zürich
E-Mail: Switzerland_ICG_team@ssga.com
Web: www.ssga.com
spdrsswitzerland@ssga.com (ETF Business)
Fund Provider State Street Global Advisors
Representative in Switzerland State Street Bank GmbH, München, Zweigniederlassung Zürich
Zürich
Phone: +41 44 560 50 00
Distributor(s) State Street Global Advisors
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Ireland
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Fund is to track the performance of large sized U. S. health care companies in the S&P 500 Index.
Peculiarities

Fund Prices

Current Price * 44.36 USD 26.11.2024
Previous Price * 44.15 USD 25.11.2024
52 Week High * 47.56 USD 02.09.2024
52 Week Low * 38.84 USD 28.11.2023
NAV * 44.36 USD 26.11.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 410,117,309
Unit/Share Assets *** 410,117,309
Trading Information SIX

Performance

YTD Performance +8.18% 29.12.2023
26.11.2024
YTD Performance (in CHF) +13.91% 29.12.2023
26.11.2024
1 month -1.75% 28.10.2024
26.11.2024
3 months -5.59% 26.08.2024
26.11.2024
6 months +1.84% 27.05.2024
26.11.2024
1 year +13.65% 27.11.2023
26.11.2024
2 years +10.24% 28.11.2022
26.11.2024
3 years +15.22% 26.11.2021
26.11.2024
5 years +58.03% 26.11.2019
26.11.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 12.13%
UnitedHealth Group Inc 9.66%
Johnson & Johnson 7.13%
AbbVie Inc 6.68%
Merck & Co Inc 4.81%
Thermo Fisher Scientific Inc 3.87%
Abbott Laboratories 3.66%
Intuitive Surgical Inc 3.31%
Amgen Inc 3.19%
Pfizer Inc 2.97%
Last data update 31.10.2024

Cost / Risk

TER *** 0.15%
TER date *** 31.03.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.15%
Ongoing Charges *** 0.15%
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)